Ordering
Available Variants1 g
CHA.86632-1g
Price
€39.04
Available – Dispatch in 14 days
5 g
CHA.86632-5g
Price
€57.84
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
1 g | CHA.86632-1g | €39.04 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
5 g | CHA.86632-5g | €57.84 |
≥98% (HPLC)
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C8H15N3O4 |
|---|---|
| CAS Number | 39537-23-0 |
| Molecular Weight | 217.22 |
| UNSPSC Code | 12352209 |
| PubChem Substance ID | 24890433 |
| NACRES | NA.26 |
Safety Information Handling visibility
| Storage Class | 11 - Combustible Solids |
|---|---|
| wgk | WGK 1 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
| ppe | Eyeshields, Gloves, type N95 (US) |
Technical Overview & Applications Use-case context
Ala-Gln, also known as alanylglutamine, is a dipeptide composed of the amino acids alanine and glutamine. With a CAS number of 39537-23-0, this compound has been extensively studied for its potential therapeutic applications. Ala-Gln is highly soluble in water and has been shown to be stable under various conditions, making it a suitable candidate for use in pharmaceutical formulations. Research has demonstrated that Ala-Gln may have benefits in supporting gut health and immune function, as well as potentially serving as a fuel source for cells. Additionally, its role in medical nutrition and as a component of parenteral nutrition solutions has been explored, highlighting the importance of this dipeptide in clinical settings. Further investigation is needed to fully elucidate the mechanisms of action and potential uses of Ala-Gln.
